相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications
Elisa Dal Canto et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Glycemic Targets: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Inflammation in Diabetic Kidney Disease
Rosa E. Perez-Morales et al.
NEPHRON (2019)
The effect of dapagliflozin treatment on epicardial adipose tissue volume
Takao Sato et al.
CARDIOVASCULAR DIABETOLOGY (2018)
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Keizo Kanasaki
CLINICAL SCIENCE (2018)
Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
Juan F. Navarro-Gonzalez et al.
DIABETES CARE (2018)
Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
Krit Jaikumkao et al.
DIABETES OBESITY & METABOLISM (2018)
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Merlin C. Thomas et al.
DIABETOLOGIA (2018)
Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy
Chor Ho Jo et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
W. Timothy Garvey et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Albumin downregulates Klotho in tubular cells
Beatriz Fernandez-Fernandez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Arpeeta Sharma et al.
FRONTIERS IN PHYSIOLOGY (2018)
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
Vlado Perkovic et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
Bancha Satirapoj et al.
BMC NEPHROLOGY (2018)
Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
Iolanda Lazaro et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeting inflammation in diabetic nephropathy: a tale of hope
Juan Antonio Moreno et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance
Sachiko Hattori
JOURNAL OF DIABETES INVESTIGATION (2018)
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet
Ji Hye Han et al.
DIABETOLOGIA (2017)
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
Volker Vallon et al.
DIABETOLOGIA (2017)
C-C motif-ligand 2 inhibition with emapticap pegol ( NOX-E36) in type 2 diabetic patients with albuminuria
Jan Menne et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
Mihoko Matsumura et al.
DIABETES THERAPY (2017)
Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
Mihoko Matsumura et al.
DIABETES THERAPY (2017)
Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study
Hiroshi Tobita et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2017)
Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms
Bart Staels
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation
Y. Ishibashi et al.
HORMONE AND METABOLIC RESEARCH (2016)
Reduction in cardiovascular and all-cause mortality in the EMPA-REG OUTCOME trial: A critical analysis
Andre J. Scheen
DIABETES & METABOLISM (2016)
Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals
Yuji Ishibashi et al.
DIABETES & VASCULAR DISEASE RESEARCH (2016)
Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients
Sang Soo Kim et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Myrciaria cauliflora extract improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-nicotinamide mice
Jeng-Dong Hsu et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients
Aki Okamoto et al.
DRUGS IN R&D (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
Daiji Kawanami et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients
Radovan Hojs et al.
NEPHRON (2016)
Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy
Huei-Fen Jheng et al.
DISEASE MODELS & MECHANISMS (2015)
Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis
Mao-Lu Tian et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)
Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase
Francisca Adilfa de Oliveira Garcia et al.
JOURNAL OF INFLAMMATION-LONDON (2015)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2015)
Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
Ping Li et al.
PLOS ONE (2015)
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Stephanie Toth-Manikowski et al.
JOURNAL OF DIABETES RESEARCH (2015)
Inflammatory Cytokines in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF DIABETES RESEARCH (2015)
Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes
Jian-Jun Liu et al.
ATHEROSCLEROSIS (2014)
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Bowen Lin et al.
CARDIOVASCULAR DIABETOLOGY (2014)
The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin
Can Wu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus
Keith C. Ferdinand et al.
HYPERTENSION (2014)
Therapeutic approaches to diabetic nephropathy-beyond the RAS
Beatriz Fernandez-Fernandez et al.
NATURE REVIEWS NEPHROLOGY (2014)
Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
Naoto Terami et al.
PLOS ONE (2014)
Rho-kinase regulation of TNF-α-induced nuclear translocation of NF-κB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells
Keiichiro Matoba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
M. Barbieri et al.
ATHEROSCLEROSIS (2013)
Inflammation and the pathogenesis of diabetic nephropathy
Jun Wada et al.
CLINICAL SCIENCE (2013)
Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes
Koji Sakata et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2013)
Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α
Keiichiro Matoba et al.
KIDNEY INTERNATIONAL (2013)
Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
Su Jin Seok et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
Usha Panchapakesan et al.
PLOS ONE (2013)
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice
Timothy Sullivan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
Swenja Kroeller-Schoen et al.
CARDIOVASCULAR RESEARCH (2012)
SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
Raktim Kumar Ghosh et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial
Marian Goicoechea et al.
JOURNAL OF NEPHROLOGY (2012)
Pyridorin in Type 2 Diabetic Nephropathy
Edmund J. Lewis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
David K. Packham et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion
Osamu Asai et al.
KIDNEY INTERNATIONAL (2012)
DIABETES Treating diabetic nephropathy-still an unresolved issue
Mark E. Cooper
NATURE REVIEWS ENDOCRINOLOGY (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
Sridevi Devaraj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells
Daiji Kawanami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Klotho Depletion Contributes to Increased Inflammation in Kidney of the db/db Mouse Model of Diabetes via RelA (Serine)536 Phosphorylation
Yanhua Zhao et al.
DIABETES (2011)
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Sitagliptin reduces albuminuria in patients with type 2 diabetes
Sachiko Hattori
ENDOCRINE JOURNAL (2011)
The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB
Juan A. Moreno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
Sufyan G. Sayyed et al.
KIDNEY INTERNATIONAL (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy
Vivian Soetikno et al.
NUTRITION & METABOLISM (2011)
Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury
Alaa S. Awad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Cilostazol Ameliorates Nephropathy in Type 1 Diabetic Rats Involving Improvement in Oxidative Stress and Regulation of TGF-β and NF-κB
Wen-Chin Lee et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2010)
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise A randomized, double-blind, placebo-controlled, phase 3 trial
Ele Ferrannini et al.
DIABETES CARE (2010)
Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
A. K. H. Lim et al.
DIABETOLOGIA (2010)
Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65
Hideaki Shimada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
NF-κB in Renal Inflammation
Ana Belen Sanz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
Guadalupe Ortiz-Munoz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Avosentan for Overt Diabetic Nephropathy
Johannes F. E. Mann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Diabetic kidney disease: act now or pay later
Robert C. Atkins et al.
KIDNEY INTERNATIONAL (2010)
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Piero Ruggenenti et al.
NATURE REVIEWS NEPHROLOGY (2010)
Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
Celine C. Berthier et al.
DIABETES (2009)
Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
Kazunari Miyauchi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
A. K. H. Lim et al.
DIABETOLOGIA (2009)
Klotho suppresses TNF-α-induced expression of adhesion molecules in the endothelium and attenuates NF-κB activation
Yoshihiro Maekawa et al.
ENDOCRINE (2009)
Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-κB p65 signaling
Catherine Meyer-Schwesinger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: A 12-month randomized trial
Shuei-Liong Lin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
The effect of pentoxifylline on proteinuria in diabetic kidney disease: A meta-analysis
Brendan B. McCormick et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Late onset of Cc12 blockade with the spiegelmer mNOX-E36-3′PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice
Volha Ninichuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease - A randomized placebo-controlled study
Juliano Lara Fernandes et al.
ATHEROSCLEROSIS (2008)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Gang Jee Ko et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge
Sebastian Martini et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation
Amy K. L. Banes-Berceli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
1,25-Dihydroxyvitamin D3 targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells
Z. Zhang et al.
KIDNEY INTERNATIONAL (2007)
Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy
C. K. Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Inflammatory cells in renal injury and repair
David Ferenbach et al.
SEMINARS IN NEPHROLOGY (2007)
Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-α stimulation, and effects of a phosphodiesterase inhibitor
Nobuhiko Koike et al.
LIFE SCIENCES (2007)
Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury
X. Dong et al.
KIDNEY INTERNATIONAL (2007)
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
Sakiko Ohga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Macrophage scavenger receptor-A-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation
Hitorni Kataoka Usui et al.
DIABETES (2007)
Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease
Lynda A. O'Sullivan et al.
MOLECULAR IMMUNOLOGY (2007)
Inhibition of JAK/STAT signaling ameliorates mice experimental nephrotic syndrome
Rong Li et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
P. Dandona et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients
Juan F. Navarro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells
Amy K. Banes-Berceli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Macrophage accumulation in human progressive diabetic nephropathy
Duy Nguyen et al.
NEPHROLOGY (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Role of the JAK/STAT signaling pathway in diabetic nephropathy
MB Marrero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy
Kohzo Takebayashi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration
Juan F. Navarro et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes
A Nakamura et al.
DIABETES CARE (2005)
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade:: A short-term, randomized, controlled trial
JF Navarro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
FY Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The epidemiology of chronic kidney disease
RC Atkins
KIDNEY INTERNATIONAL (2005)
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes
M Dalla Vestra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-Mediated oxidative stress
A Modesti et al.
DIABETES (2005)
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus
A Aminorroaya et al.
NEPHRON CLINICAL PRACTICE (2005)
Protective effects of angiotensin II interruption: Evidence for antiinflammatory actions
NJ Dagenais et al.
PHARMACOTHERAPY (2005)
Pentoxifylline suppresses renal tumour necrosis factor-α and ameliorates experimental crescentic glomerulonephritis in rats
YM Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli
AK Banes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
JC Pickup
DIABETES CARE (2004)
Type 2 diabetes mellitus: a disease of the innate immune system? An update
M Crook
DIABETIC MEDICINE (2004)
Interleukin-18 enhances monocyte tumor necrosis factor α and interleukin-1β production induced by direct contact with T lymphocytes -: Implications in rheumatoid arthritis
SM Dai et al.
ARTHRITIS AND RHEUMATISM (2004)
Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat
ME Dávila-Esqueda et al.
EXPERIMENTAL DIABESITY RESEARCH (2004)
Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy
FTH Lee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
G Wolf
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure
A Cooper et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
Juxtagiomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients
R Moriya et al.
DIABETOLOGIA (2004)
Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats
K DiPetrillo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
NF-κB activation and overexpression of regulated genes in human diabetic nephropathy
S Mezzano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes
S Okada et al.
DIABETES (2003)
Tumor necrosis factor-α promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms
JJ Boyle et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Progression to overt nephropathy in type 2 diabetes - The Casale Monferrato study
G Bruno et al.
DIABETES CARE (2003)
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus
JF Navarro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)
E Mariño et al.
CYTOKINE (2003)
Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-κB pathways
DZ Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus:: Relationship with diabetic nephropathy
Y Moriwaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat
OME Abdel-Salam et al.
PHARMACOLOGICAL RESEARCH (2003)
Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation
DM Lenda et al.
JOURNAL OF IMMUNOLOGY (2003)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
K DiPetrillo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes
RJL Stuyt et al.
IMMUNOLOGY (2003)
IFNγ induces functional chemokine receptor expression in human mesangial cells
M Schwarz et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
F Amiri et al.
KIDNEY INTERNATIONAL (2002)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure
VY Melnikov et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Transcription factor-κB (NF-κB) and renal disease
C Guijarro et al.
KIDNEY INTERNATIONAL (2001)
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy
T Wada et al.
KIDNEY INTERNATIONAL (2000)
Effects of pentoxifylline, pentifylline and γ-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts
F Strutz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:: The Insulin Resistance Atherosclerosis Study
A Festa et al.
KIDNEY INTERNATIONAL (2000)
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
P Clausen et al.
DIABETIC MEDICINE (2000)
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
N Banba et al.
KIDNEY INTERNATIONAL (2000)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate
R Nosadini et al.
DIABETES (2000)
分享论文
